Boston Children's Hospital presented research at the recent ADA Scientific Sessions in Philadelphia PA on Closed-loop insulin delivery, also known as the "artificial pancreas."
In this study, overnight delivery of insulin via a pump in young children did not change the time in the target range for glucose, but significantly fewer kids spent time above 300 mg/dL overnight with closed-loop delivery.